zealthy glp 1 f4a06a46-cross-insulin-pen-header_105e07m05e04y00000c028.png getZealthy
Description
doi: 10.1111/dom.14174 [DOI] [PMC free article] [PubMed] [Google Scholar] 181
Maybe your insurance stopped covering it (one of the most common reasons people quit taking GLP-1 drugs like Ozempic or Zepbound)
Compared with GLP-1 RAs, more participants receiving tirzepatide 15 mg discontinued treatment due to adverse events (OR 2.29 [95% CI 1.39, 3.75], I 2 0%), whereas no difference was evident for tirzepatide 5 mg and 10 mg (ESM Table 3)
Transl Med Exerc Prescr
For this reason, most providers recommend erring on the side of caution
